Laurus Labs to meet BofA, Macquarie investors in June

Laurus Labs Limited has scheduled a series of meetings with analysts and institutional investors in Hyderabad for June 2026. The company will engage with BofA and Macquarie as part of their respective healthcare tours through in-person interactions. These meetings are intended to facilitate discussions regarding the company's operations and performance without disclosing any unpublished price sensitive information.

The schedule includes two key events in June. On June 05, 2026, the company will meet with BofA Healthcare Tour, followed by a session with Macquarie Healthcare Tour on June 10, 2026. Both interactions will take place in Hyderabad and will be conducted as in-person meetings. The dates for these interactions remain subject to change due to exigencies on the part of the investors or the company.

Investor Meeting Schedule

Date	Analyst / Investors / Event	Place	Type of Interaction
June 05, 2026	BofA Healthcare Tour	Hyderabad	In-Person Meeting
June 10, 2026	Macquarie Healthcare Tour	Hyderabad	In-Person Meeting

The intimation was submitted to the stock exchanges pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. G. Venkateswar Reddy, Company Secretary & Compliance Officer, signed the disclosure on May 29, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.43%	+0.07%	+21.22%	+35.77%	+126.32%	+161.62%

Laurus Labs witnessed a notable block trade on the National Stock Exchange (NSE), with approximately 252,673 shares transacted in a single deal. The trade was executed at a price of ₹1345.90 per share, aggregating to a total transaction value of ₹34.01 crores.

Block Trade Details

The following table summarises the key parameters of the block trade recorded on the NSE:

Parameter:	Details
Exchange:	NSE
Number of Shares:	~252,673
Trade Price:	₹1345.90 per share
Total Trade Value:	₹34.01 crores

Block trades of this scale are typically associated with large institutional investors or significant stakeholders executing bulk transactions outside the regular market order book. The trade in Laurus Labs reflects considerable activity at the institutional level in the stock.